Carbonic anhydrase IX is highly expressed in hereditary nonpolyposis colorectal cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 9, 2007, Pages 1760-1766

  Niemelä, Anssi M ^b,c   Hynninen, Piritta ^c   Mecklin, Jukka Pekka ^a   Kuopio, Teijo ^a   Kokko, Antti ^d   Aaltonen, Lauri ^d   Parkkila, Anna Kaisa ^c   Pastorekova, Silvia ^e   Pastorek, Jaromir ^e   Waheed, Abdul ^f   Sly, William S ^f   Ørntoft, Torben F ^g   Kruhøffer, Mogens ^g   Haapasalo, Hannu ^c   Parkkila, Seppo ^b   Kivelä, Antti J ^a  

^a JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e INSTITUTE OF VIROLOGY   (Slovakia)

^f SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII; ISOENZYME; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FAMILIAL CANCER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC STABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34548847162     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0080     Document Type: Article

References (48)

1. Boland CR. Decoding hereditary colorectal cancer. N Engl J Med 2006;354:2815-7.
2. de la Chapelle A. Microsatellite instability. N Engl J Med 2003;349:209-10.
3. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
4. Kouraklis G, Misiakos EP. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management. Dig Dis Sci 2005;50:336-44.
5. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996;56:5754-7.
6. Koshiji M, To KK, Hammer S, et al. HIF-1α induces genetic instability by transcriptionally down-regulating MutSα expression. Mol Cell 2005;17:793- 803.
7. Pastorekova S, Parkkila S, Zavada J. Tumor-associated carbonic anhydrases and their clinical significance. Adv Clin Chem 2006;42:167-216.
8. Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000;60:7075-83.
9. Tureci O, Sahin U, Vollmar E, et al. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A 1998;95:7608-13.
10. Yoshiura K, Nakaoka T, Nishishita T, et al. Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res 2005;11:8201-7.
11. Haapasalo J, Nordfors K, Jarvela S, et al. Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy. Neuro Oncol 2007;9:308-13.
12. Pastorek J, Pastorekova S, Callebaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-88.
13. Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD, Jr., Chen LB. The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 1993;105:820-6.
14. Saarnio J, Parkkila S, Parkkila AK, et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 1998;153:279-85.
15. Kivela A, Parkkila S, Saarnio J, et al. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am J Pathol 2000;156:577-84.
16. Kivela AJ, Saarnio J, Karttunen TJ, et al. Differential expression of cytoplasmic carbonic anhydrases, CA I and II, and membraneassociated isozymes, CA IX and XII, in normal mucosa of large intestine and in colorectal tumors. Dig Dis Sci 2001;46:2179-86.
17. Saarnio J, Parkkila S, Parkkila AK, et al. Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity. J Histochem Cytochem 1998;46:497-504.
18. Ivanov SV, Kuzmin I, Wei MH, et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci U S A 1998;95:12596-601.
19. Kivela J, Parkkila S, Parkkila AK, Rajaniemi H. [Carbonic anhydrases protect teeth and upper gastrointestinal mucosa]. Duodecim 2000;116:2105-9.
20. Yuan J, Narayanan L, Rockwell S, Glazer PM. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 2000;60:4372-6.
21. Svastova E, Hulikova A, Rafajova M, et al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 2004;577:439-45.
22. Kruhoffer M, Jensen JL, Laiho P, et al. Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br J Cancer 2005;92:2240-8.
23. Parkkila AK, Parkkila S, Juvonen T, Rajaniemi H. Carbonic anhydrase isoenzymes II and I are present in the zona glomerulosa cells of the human adrenal gland. Histochemistry 1993;99:37-41.
24. Karhumaa P, Parkkila S, Tureci O, et al. Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium. Mol Hum Reprod 2000;6:68-74.
25. Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J. A novel quasi-viral agent, MaTu, is a two-component system. Virology 1992;187:620-6.
26. Leppilampi M, Saarnio J, Karttunen TJ, et al. Carbonic anhydrase isozymes IX and XII in gastric tumors. World J Gastroenterol 2003;9:1398-403.
27. Kummola L, Hamalainen JM, Kivela J, et al. Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa. BMC Cancer 2005;5:41.
28. Ivanov S, Liao SY, Ivanova A, et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 2001;158:905-19.
29. Maxwell P. HIF-1: an oxygen response system with special relevance to the kidney. J Am Soc Nephrol 2003;14:2712-22.
30. Soyupak B, Erdogan S, Ergin M, Seydaoglu G, Kuzgunbay B, Tansug Z. CA9 expression as a prognostic factor in renal clear cell carcinoma. Urol Int 2005;74:68-73.
31. Kim HL, Seligson D, Liu X, et al. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 2005;173:1496-501.
32. Pastorekova S, Zavada J. Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy. Cancer Ther 2004;2:245-62.
33. Bui MH, Seligson D, Han KR, et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 2003;9:802-11.
34. Elsakov P, Kurtinaitis J. Survival from colorectal carcinoma in HNPCC families as compared to the general population in lithuania - initial results. Fam Cancer 2006;5:369-71.
35. Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL. Relationship of hypoxia-inducible factor (HIF)-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 2000;60:7106-13.
36. Jiang BH, Agani F, Passaniti A, Semenza GL. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 1997;57:5328-35.
37. Kuwai T, Kitadai Y, Tanaka S, et al. Expression of hypoxia-inducible factor-1α is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 2003;105:176-81.
38. Koukourakis MI, Giatromanolaki A, Polychronidis A, et al. Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Sci 2006;97:582-8.
39. Parkkila S, Parkkila AK, Juvonen T, Rajaniemi H. Distribution of the carbonic anhydrase isoenzymes I, II, and VI in the human alimentary tract. Gut 1994;35:646-50.
40. Parkkila S, Kivela AJ, Kaunisto K, et al. The plasma membrane carbonic anhydrase in murine hepatocytes identified as isozyme XIV. BMC Gastroenterol 2002;2:13.
41. Pastorekova S, Parkkila S, Parkkila AK, et al. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 1997;112:398-408.
42. Fleming RE, Parkkila S, Parkkila AK, Rajaniemi H, Waheed A, Sly WS. Carbonic anhydrase IV expression in rat and human gastrointestinal tract regional, cellular, and subcellular localization. J Clin Invest 1995;96:2907-13.
43. Saarnio J, Parkkila S, Parkkila AK, Waheed A, Karttunen T, Sly WS. Cell-specific expression of mitochondrial carbonic anhydrase in the human and rat gastrointestinal tract. J Histochem Cytochem 1999;47:517-24.
44. Lehtonen J, Shen B, Vihinen M, et al. Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. J Biol Chem 2004;279:2719-27.
45. Clark AM. Carbonic anhydrase activity during embryonic development. J Exp Biol 1951;28:332-43.
46. Fleming RE, Crouch EC, Ruzicka CA, Sly WS. Pulmonary carbonic anhydrase IV: developmental regulation and cell-specific expression in the capillary endothelium. Am J Physiol 1993;265:L627-35.
47. Bekku S, Mochizuki H, Takayama E, et al. Carbonic anhydrase I and II as a differentiation marker of human and rat colonic enterocytes. Res Exp Med (Berl) 1998;198:175-85.
48. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199-229.